6 completed. 4 Phase 1, 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Not applicable | 2 | Completed 2 |
Follow FluGen Inc: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Immunogenicity of Cam2020 M2SR H3N2 Monovalent Influenza Vaccine Alone or With Licensed IIV in Older Adults Cam2020 M2SR H3N2 influenza vaccine, Fluzone HD IIV, IN Placebo - Influenza Vaccine | Phase 1 | Completed | FluGen Inc | 303 | 2022-06-14 | 2022-11-14 |
| Safety and Immunogenicity of the Sing2016 M2SR H3N2 Monovalent Influenza Vaccine in Adults Ages 50 to 85 Years Old Sing2016 M2SR H3N2 influenza vaccine, Placebo - Influenza Vaccine | Phase 1 | Completed | FluGen Inc | 122 | 2021-06-30 | 2023-06-15 |
| Safety and Immunogenicity of the Bris10 M2SR and Sing2016 M2SR H3N2 Monovalent Influenza Vaccines LD Sing2016 M2SR H3N2 influenza vaccine, MD Sing2016 M2SR H3N2 influenza vaccine, HD Sing2016 M2SR H3N2 influenza vaccine - Influenza A | Phase 1 | Completed | FluGen Inc | 206 | 2019-09-03 | 2022-03-04 |
| Safety and Immunogenicity Study of H3N2 M2SR Monovalent Influenza Vaccine in Healthy Volunteers the H3N2 M2SR monovalent influenza vaccine, Placebo - Flu | Phase 1 | Completed | FluGen Inc | 96 | 2016-06-01 | 2020-08-10 |
| Site Selection for Intracutaneous Saline Delivery Injection to deltoid, Injection to forearm, Injection to thigh - Intracutaneous Drug Delivery | Not applicable | Completed | FluGen Inc | 12 | 2012-12-01 | 2017-08-02 |
| Intracutaneous Delivery of Varied Dose Volumes of Saline FLUGEN 101.2 device - Influenza | Not applicable | Completed | FluGen Inc | 24 | 2012-12-01 | 2017-08-02 |
Influenza, Human (4)
United States (6)
Pamuk Bilsel (3) · Renee Herber (3) · Carlos Fierro, MD (2) · Murray A Kimmel, DO (2)